Interview: Jason Smith, Managing Director, Novartis Australia
After just six months in the country, Novartis Australia’s new Managing Director offers his…
Novartis Australia
Last updated: 01.06.2015
Address: 54 Waterloo Road, North Ryde NSW 2113,Australia
Tel: +61 2 9805 3555
Web: http://www.novartis.com.au/
Company description
Novartis is a diversified healthcare company and our uniquely broad business portfolio focuses on science-based healthcare sectors that are growing, reward innovation and enhance the lives of patients.
We employ over 700 people in Australia and invest more than AUD 24million annually in local research. This research assures the quality of the company’s current range of treatments as well as the promise of improving future health outcomes.
Products and services
nnovation is fundamental to our business. In 2010, we invested 16% of global net sales across our divisions in R&D and we will sustain our high level of investment. Novartis is consistently rated as having one of the industry’s most respected pharmaceutical development pipelines with more than 130 projects in pharmaceutical clinical development. Our mission is to care and cure.
Interviews
Related
Australia / Opportunities for the Life Science Industry post-COVID
Regular PharmaBoardroom contributor Brendan Shaw outlines how his home country of Australia has so far successfully…
Australia / Growing Clinical Trials Even in Pandemic’s Wake
In an exclusive new podcast, DIA Global Forum Australia/New Zealand Regional Editor Richard Day (University of…
Opinion / The Powerful Impact of Taking a Patient-Centric Approach in an Evolving Health Landscape
Janssen Australia & New Zealand’s Bruce Goodwin argues that greater adoption of patient-centric practices…
Interview with Mal Eutick, CEO, Phebra Australia
Can you start by giving our readers a brief overview of the company’s history here and your most notable…
Interview with Marisa Petersen, Managing Director, George Clinical, Australia
Would you begin by outlining the role & importance of George Clinical within the George Institute, highlighting…
Interview with Vlado Perkovich, Executive Director, The George Institute,…
Would you begin by giving an introduction to our international readers of the institute, highlighting recent…
Interview with John Chalmers, Senior Director, The George Institute
For those that are not familiar with your name, would you start by introducing yourself? After obtaining my PhD in…
Interview with Megan Fookes, Director, Rare Voices
Rare Voices Australia is a new organisation that has been established after the national rare diseases symposium in…
Australia: Where Value Beats Cost
In some ways the Australian medicines industry is going through the same restructuring and challenges as the…
Interview with Craig Moore, Director, Hahn Healthcare
Can you outline the significance of the current PBS to the industry and in particular the impact it has on service…
Interview with Radek Sali, CEO, SWISSE
Speaking to the Australian environment, how would you rate the market in terms of companies like Swisse? After…
Interview with Albert Spanos, General Manager, Celgene Australia
In our interviews we have been hearing two opinions on the success of PBS reforms: that it works as it should in…
